HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

E H Estey Selected Research

Refractory Anemia with Excess of Blasts (RAEM)

11/2005Risk factors of myelodysplastic syndromes: a case-control study.
11/2003Antithymocyte globulin (ATG)-based therapy in patients with myelodysplastic syndromes.
12/2001Comparison of idarubicin + ara-C-, fludarabine + ara-C-, and topotecan + ara-C-based regimens in treatment of newly diagnosed acute myeloid leukemia, refractory anemia with excess blasts in transformation, or refractory anemia with excess blasts.
10/2001High-dose chemotherapy in high-risk myelodysplastic syndrome: covariate-adjusted comparison of five regimens.
1/2000Effect of time to complete remission on subsequent survival and disease-free survival time in AML, RAEB-t, and RAEB.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


E H Estey Research Topics

Disease

13Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2017 - 01/2000
7Neoplasms (Cancer)
12/2017 - 01/2000
5Leukemia
12/2017 - 07/2001
5Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2017 - 07/2001
5Refractory Anemia with Excess of Blasts (RAEM)
11/2005 - 01/2000
3Refractory Anemia
12/2001 - 01/2000
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2017 - 07/2001
1Acute Promyelocytic Leukemia
11/2017
1Myeloid Leukemia (Leukemia, Myelocytic)
01/2017
1Residual Neoplasm
01/2016
1Pathologic Complete Response
07/2005
1Graft vs Host Disease (Graft-Versus-Host Disease)
08/2001
1Blast Crisis (Blast Phase)
07/2001
1Hyperbilirubinemia
07/2001
1Infections
03/2001
1Fever (Fevers)
03/2001

Drug/Important Bio-Agent (IBA)

3Cytarabine (Cytosar-U)FDA LinkGeneric
12/2017 - 12/2001
2DecitabineFDA Link
12/2017 - 09/2013
1DNA (Deoxyribonucleic Acid)IBA
12/2017
1Mitoxantrone (Novantrone)FDA LinkGeneric
12/2017
1MethyltransferasesIBA
12/2017
1Etoposide (VP 16)FDA LinkGeneric
12/2017
1Arsenic Trioxide (Trisenox)FDA Link
11/2017
1Leukocyte Elastase (Neutrophil Elastase)IBA
01/2017
1MDS 11IBA
01/2017
1Peptides (Polypeptides)IBA
01/2017
1Protein Subunit VaccinesIBA
01/2017
1Myeloblastin (Proteinase 3)IBA
01/2017
1Azacitidine (5 Azacytidine)FDA Link
09/2013
1SolventsIBA
11/2005
1Agrochemicals (Agricultural Chemicals)IBA
11/2005
1Cyclosporine (Ciclosporin)FDA LinkGeneric
11/2003
1Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
11/2003
1fludarabineIBA
12/2001
1Topotecan (Hycamtin)FDA LinkGeneric
12/2001
1Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
12/2001
1Tacrolimus (Prograf)FDA LinkGeneric
08/2001
1Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric
08/2001
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
08/2001
1Busulfan (Busulfex)FDA Link
08/2001
1Monoclonal AntibodiesIBA
07/2001
1Gemtuzumab (Mylotarg)FDA Link
07/2001
1CalicheamicinsIBA
07/2001
1Anti-Bacterial Agents (Antibiotics)IBA
03/2001
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
03/2001
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
03/2001
1CytokinesIBA
03/2001

Therapy/Procedure

8Therapeutics
11/2017 - 01/2000
5Drug Therapy (Chemotherapy)
11/2017 - 01/2000
1Aftercare (After-Treatment)
11/2017
1Cell Transplantation
01/2016
1Investigational Therapies (Experimental Therapy)
05/2012
1Hematopoietic Stem Cell Transplantation
07/2005
1Stem Cell Transplantation
08/2001
1Homologous Transplantation
08/2001
1Salvage Therapy
03/2000